{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T02:35:39Z","timestamp":1790044539134,"version":"4.0.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"vor","delay-in-days":731,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jvascsurg.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Vascular Surgery"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.jvs.2017.09.057","type":"journal-article","created":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T20:33:28Z","timestamp":1517517208000},"page":"176-181.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Rationale and design of the Clinical and Histologic Analysis of Mesenchymal Stromal Cells in AmPutations (CHAMP) trial investigating the therapeutic mechanism of mesenchymal stromal cells in the treatment of critical limb ischemia"],"prefix":"10.1016","volume":"68","author":[{"given":"S. Keisin","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linden A.","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie A.","family":"Drucker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raghu L.","family":"Motaganahalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andres","family":"Fajardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1016\/j.jvs.2017.09.057_bib1","first-page":"S1","article-title":"Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)","volume":"33","author":"Norgren","year":"2007","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2017.09.057_bib2","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0140-6736(02)09670-8","article-title":"Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial","volume":"360","author":"Tateishi-Yuyama","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jvs.2017.09.057_bib3","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1016\/j.jvs.2017.01.054","article-title":"Rationale and design of the MarrowStim PAD Kit for the Treatment of Critical Limb Ischemia in Subjects with Severe Peripheral Arterial Disease (MOBILE) trial investigating autologous bone marrow cell therapy for critical limb ischemia","volume":"65","author":"Wang","year":"2017","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2017.09.057_bib4","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jvs.2014.06.089","article-title":"Bone marrow aspirate injection for treatment of critical limb ischemia with comparison to patients undergoing high-risk bypass grafts","volume":"61","author":"Giles","year":"2015","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2017.09.057_bib5","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/j.jvs.2016.01.022","article-title":"Autologous bone marrow mononuclear cell therapy for critical limb ischemia is effective and durable","volume":"63","author":"Liang","year":"2016","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2017.09.057_bib6","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/j.jvs.2011.01.074","article-title":"Autologous bone marrow mononuclear cell therapy is safe and promotes amputation-free survival in patients with critical limb ischemia","volume":"53","author":"Murphy","year":"2011","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2017.09.057_bib7","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1476-9255-2-8","article-title":"Mesenchymal stem cells avoid allogeneic rejection","volume":"2","author":"Ryan","year":"2005","journal-title":"J\u00a0Inflamm (Lond)"},{"key":"10.1016\/j.jvs.2017.09.057_bib8","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects","volume":"310","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.jvs.2017.09.057_bib9","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/14653240600855905","article-title":"Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement","volume":"8","author":"Dominici","year":"2006","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jvs.2017.09.057_bib10","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.apmr.2004.06.072","article-title":"Reamputation, mortality, and health care costs among persons with dysvascular lower-limb amputations","volume":"86","author":"Dillingham","year":"2005","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.jvs.2017.09.057_bib11","first-page":"14","article-title":"Lower extremity amputation: a contemporary series","volume":"103","author":"Stone","year":"2007","journal-title":"W\u00a0V Med J"},{"key":"10.1016\/j.jvs.2017.09.057_bib12","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/j.1445-2197.2006.03715.x","article-title":"Outcomes of a contemporary amputation series","volume":"76","author":"Lim","year":"2006","journal-title":"A\u00a0N Z J Surg"},{"key":"10.1016\/j.jvs.2017.09.057_bib13","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0741-5214(03)00092-2","article-title":"Functional outcome in a contemporary series of major lower extremity amputations","volume":"38","author":"Nehler","year":"2003","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2017.09.057_bib14","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1161\/01.CIR.0000124476.32871.E3","article-title":"Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease","volume":"109","author":"Heeschen","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2017.09.057_bib15","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.mad.2007.06.009","article-title":"Age-related BM-MNC dysfunction hampers neovascularization","volume":"128","author":"Sugihara","year":"2007","journal-title":"Mech Ageing Dev"},{"key":"10.1016\/j.jvs.2017.09.057_bib16","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/j.jtcvs.2009.08.052","article-title":"Aging impairs the angiogenic response to ischemic injury and the activity of implanted cells: combined consequences for cell therapy in older recipients","volume":"139","author":"Zhuo","year":"2010","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jvs.2017.09.057_bib17","doi-asserted-by":"crossref","first-page":"142","DOI":"10.5966\/sctm.2011-0018","article-title":"Concise review: role of mesenchymal stem cells in wound repair","volume":"1","author":"Maxson","year":"2012","journal-title":"Stem Cells Transl Med"},{"key":"10.1016\/j.jvs.2017.09.057_bib18","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1479-5876-6-45","article-title":"Allogeneic endometrial regenerative cells: an \u201coff the shelf solution\u201d for critical limb ischemia?","volume":"6","author":"Murphy","year":"2008","journal-title":"J\u00a0Transl Med"},{"key":"10.1016\/j.jvs.2017.09.057_bib19","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1634\/stemcells.2007-0226","article-title":"Mesenchymal stem cells enhance wound healing through differentiation and angiogenesis","volume":"25","author":"Wu","year":"2007","journal-title":"Stem Cells"},{"key":"10.1016\/j.jvs.2017.09.057_bib20","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1165\/rcmb.2005-0175RC","article-title":"Failure of bone marrow to reconstitute lung epithelium","volume":"33","author":"Kotton","year":"2005","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.jvs.2017.09.057_bib21","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/mt.2009.62","article-title":"Repair of tissues by adult stem\/progenitor cells (MSCs): controversies, myths, and changing paradigms","volume":"17","author":"Prockop","year":"2009","journal-title":"Mol Ther"},{"key":"10.1016\/j.jvs.2017.09.057_bib22","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1001\/jama.2012.25321","article-title":"Comparison of allogeneic vs autologous bone marrow-derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial","volume":"308","author":"Hare","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.jvs.2017.09.057_bib23","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/S0140-6736(08)60690-X","article-title":"Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study","volume":"371","author":"Le Blanc","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.jvs.2017.09.057_bib24","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1378\/chest.12-2094","article-title":"A\u00a0placebo-controlled, randomized trial of mesenchymal stem cells in COPD","volume":"143","author":"Weiss","year":"2013","journal-title":"Chest"},{"key":"10.1016\/j.jvs.2017.09.057_bib25","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/wics.1314","article-title":"Why the Monte Carlo method is so important today","volume":"6","author":"Kroese","year":"2014","journal-title":"Wiley Interdiscip Rev Comput Stat"},{"key":"10.1016\/j.jvs.2017.09.057_bib26","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/BF01061470","article-title":"Smooth nonparametric maximum likelihood estimation for population pharmacokinetics, with application to quinidine","volume":"20","author":"Davidian","year":"1992","journal-title":"J\u00a0Pharmacokinet Biopharm"},{"key":"10.1016\/j.jvs.2017.09.057_bib27","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1080\/01621459.1963.10500843","article-title":"Ordered hypotheses for multiple treatments: a significance test for linear ranks","volume":"58","author":"Page","year":"1963","journal-title":"J\u00a0Am Stat Assoc"}],"container-title":["Journal of Vascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0741521417326721?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0741521417326721?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T20:21:27Z","timestamp":1760041287000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0741521417326721"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["S0741521417326721"],"URL":"https:\/\/doi.org\/10.1016\/j.jvs.2017.09.057","relation":{},"ISSN":["0741-5214"],"issn-type":[{"value":"0741-5214","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rationale and design of the Clinical and Histologic Analysis of Mesenchymal Stromal Cells in AmPutations (CHAMP) trial investigating the therapeutic mechanism of mesenchymal stromal cells in the treatment of critical limb ischemia","name":"articletitle","label":"Article Title"},{"value":"Journal of Vascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvs.2017.09.057","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier Inc. on behalf of the Society for Vascular Surgery.","name":"copyright","label":"Copyright"}]}}